Journal of the Korean Academy of Child and Adolescent Psychiatry : eISSN 2233-9183 / pISSN 1225-729X

Table. 1.

Table. 1.

Comparison of demographic features of MPH and ATX-treated groups


MPH (n=35) ATX (n=9) p-value
Age (mean±SD, yr) 19.54±4.00 17.78±2.68 0.219
Duration of illness (mean±SD, yr) 4.40±3.93 4.11±2.98 0.838
Sex
Male 26 8 0.657
Female 9 1
Full scale IQ (mean±SD) 94.42±15.82 95.29±11.47 0.892
Dose (mean±SD, mg) 45.79±21.99 71.78±23.82
Cormorbid diagnosis (%)
Depressive disorder 21 (60) 3 (33) 0.334
Anxiety disorder 2 (6) 3 (33) 0.028
Obsessive compulsive disorder 2 (6) 0
Tic disorder 0 2 (22)
Conduct disorder 1 (3) 0
Bipolar disorder 1 (3) 0
Schizophrenia 1 (3) 0
Concommitant antidepressants (%)
Escitalopram (5-30 mg) 18 (51) 5 (56) 0.879
Fluoxetine (20 mg) 1 (3) 0
Brintellix (10-20 mg) 1 (3) 1 (11)
Bupropion (300 mg) 1 (3) 0
Concommitant antipsychotics (%)
Risperidone (1-5 mg) 2 (6) 2 (22) 0.143
Olanzapine (20 mg) 1 (3) 0
Aripiprazole (5-25 mg) 3 (9) 2 (22)

SD: standard deviation, MPH: methylphenidate, ATX: atomoxetine, IQ: intelligence quotient

J Korean Acad Child Adolesc Psychiatry 2021;32:10-6 https://doi.org/10.5765/jkacap.200024
© 2021 J Korean Acad Child Adolesc Psychiatry